Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.86% is 62% below its 5-year average of 4.87%, near the low end of its 5-year range (0.00%–30.21%).
As of the fiscal period ended Tuesday, June 30, 2026. 74.14% above its 12-month average of 1.07%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.86%.
DEBT TO ASSETS RATIO
1.86%
DEBT TO ASSETS RATIO AVG TTM
1.07%
DEBT TO ASSETS RATIO AVG 3Y
1.37%
DEBT TO ASSETS RATIO AVG 5Y
4.87%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+74.14%
CURRENT VS 3Y AVG
+35.95%
CURRENT VS 5Y AVG
-61.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+1962.06%
vs the sector median at left
Tectonic Therapeutic, Inc.
Market Cap
$422.86M
Debt to Assets Ratio
1.86%
TTM Avg
1.07%
3Y Avg
1.37%
5Y Avg
4.87%
Market Cap
$422.72M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$419.87M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$426.51M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$418.95M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.27M
Debt to Assets Ratio
0.35%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | $422.86M | 1.86% | 1.07% | 1.37% | 4.87% |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | 0.17% | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 0.33% | N/A | N/A | N/A |
| Prothena Corporation plc (PRTA)vs › | $419.87M | 0.02% | N/A | N/A | N/A |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | 0.69% | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | 0.07% | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 0.35% | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 0.01% | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | 0.72% | N/A | N/A | N/A |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 0.01% | N/A | N/A | N/A |
Debt/Assets
1.9%
Debt/Equity
0.02
Current Ratio
22.29
Interest Coverage
-1333.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.86% |
| 2026-03-31 | 1.88% |
| 2025-12-31 | 0.49% |
| 2025-09-30 | 0.45% |
| 2025-06-30 | 0.66% |
| 2025-03-31 | 0.84% |
| 2024-12-31 | 2.16% |
| 2024-09-30 | 1.77% |
| 2024-06-30 | 1.78% |
| 2024-03-31 | 4.47% |
| 2023-12-31 | 11.02% |
| 2023-09-30 | 30.21% |
| 2023-06-30 | 1.78% |
| 2023-03-31 | 22.09% |
| 2022-12-31 | 12.27% |
| 2022-09-30 | 11.74% |
| 2022-06-30 | 10.33% |
| 2022-03-31 | 8.57% |
| 2021-12-31 | 3.21% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
